This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by COHEN, P. Articles by ROSENFELD, R. G. Search for Related Content PubMed PubMed Citation Articles by COHEN, P. Articles by ROSENFELD, R. G.

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells^*

PINCHAS COHEN, DONNA M. PEEHL, GEORGE LAMSON and RON G. ROSENFELD

Departments of Pediatrics and Urology, Stanford University Medical Center Stanford, California 94305

Address all correspondence and requests for reprints to: Pinchas Cohen, M.D., Division of Pediatric Endocrinology, Department of Pediatrics, Room S-322, Stanford University Medical Center, Stanford, California 94305.

Insulin-like growth factors (IGFs) are potent mitogens that bind with high affinity and specificity to IGF receptors and IGF-binding proteins (IGFBPs). We studied the roles of these three groups of proteins in prostate epithelial cells (PEC) in primary culture grown under serum-free conditions. Affinity cross-linking of IGF-I and IGF-II to crude membranes prepared from PEC revealed an abundance of type 1 IGF receptors and no evidence of type 2 IGF receptors. Western ligand blots of conditioned media (CM) from PEC demonstrated the presence of two specific IGFBP bands similar to those previously demonstrated in seminal plasma, with approximate mol wt of 31 and 24 kDa. The 31-kDa band was immunoprecipitable with an antibody to IGFBP-2, and neither band could be deglycosylated with endoglycosidase-F. Northern blot analysis of poly(A)⁺ RNA prepared from PEC with cDNAs for hIGFBP-1, -2, and -3 documented the expression of mRNA for hIGFBP-2 only. Modifications of the serum-free conditions of PEC did not significantly alter the IGFBP profile of PEC CM. The ability of IGF-I, IGF-II, and insulin to stimulate clonal growth of PEC was examined. IGF-I stimulated PEC growth with an ED₅₀ of 0.1 ng/mL. IGF-II and insulin, respectively, were 1 and 3 orders of magnitude less effective than IGF-I in stimulating the growth of PEC. Radioimmunoassayable IGF-I and IGF-II levels in PEC CM were below the assay detection levels. In conclusion, we suggest that IGFs are important growth stimulators of PEC in culture, that their actions are mediated through the type 1 IGF receptor, and that PEC produce hIGFBP-2 and a 24-kDa IGFBP which may modulate IGF action in these cells.

^* This work was supported in part by Grant DK-28229 from the NIH (to R.G.R.).

Juvenile Diabetes Foundation Fellow.

Received September 17, 1990.

This article has been cited by other articles:

				S. Patane and F. Marte Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system Eur. Heart J., May 2, 2009; 30(10): 1169 - 1170. [Abstract] [Full Text] [PDF]

				H. Schayek, K. Haugk, S. Sun, L. D. True, S. R. Plymate, and H. Werner Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor-Dependent Manner Clin. Cancer Res., March 1, 2009; 15(5): 1558 - 1565. [Abstract] [Full Text] [PDF]

				J. Svensson, J. Kindblom, R. Shao, S. Moverare-Skrtic, M. K Lagerquist, N. Andersson, K. Sjogren, K. Venken, D. Vanderschueren, J.-O. Jansson, et al. Liver-derived IGF1 enhances the androgenic response in prostate J. Endocrinol., December 1, 2008; 199(3): 489 - 497. [Abstract] [Full Text] [PDF]

				W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198. [Abstract] [Full Text] [PDF]

				G. Pandini, M. Genua, F. Frasca, S. Squatrito, R. Vigneri, and A. Belfiore 17{beta}-Estradiol Up-regulates the Insulin-like Growth Factor Receptor through a Nongenotropic Pathway in Prostate Cancer Cells Cancer Res., September 15, 2007; 67(18): 8932 - 8941. [Abstract] [Full Text] [PDF]

				N. E. Allen, T. J. Key, P. N. Appleby, R. C. Travis, A. W. Roddam, S. Rinaldi, L. Egevad, S. Rohrmann, J. Linseisen, T. Pischon, et al. Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1121 - 1127. [Abstract] [Full Text] [PDF]

				J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis, March 1, 2007; 28(3): 713 - 723. [Abstract] [Full Text] [PDF]

				J. K. Parsons, H. B. Carter, A. W. Partin, B. G. Windham, E. J. Metter, L. Ferrucci, P. Landis, and E. A. Platz Metabolic Factors Associated with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2562 - 2568. [Abstract] [Full Text] [PDF]

				G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. D. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1137 - 1141. [Abstract] [Full Text] [PDF]

				I. Cheng, D. O. Stram, K. L. Penney, M. Pike, L. Le Marchand, L. N. Kolonel, J. Hirschhorn, D. Altshuler, B. E. Henderson, and M. L. Freedman Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort J Natl Cancer Inst, January 18, 2006; 98(2): 123 - 134. [Abstract] [Full Text] [PDF]

				S. J. Freedland, W. J. Aronson, B. Trock, P. Cohen, C. J. Kane, C. L. Amling, J. C. Presti Jr., M. K. Terris, and for the Shared Equal Access Regional Cancer Hospit Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy Clin. Cancer Res., November 1, 2005; 11(21): 7735 - 7742. [Abstract] [Full Text] [PDF]

				D. P. Udrisar, M. I. Wanderley, R. C. C. Porto, C. L. P. Cardoso, M. C. L. Barbosa, M. C. Camberos, and J. C. Cresto Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus Experimental Biology and Medicine, July 1, 2005; 230(7): 479 - 486. [Abstract] [Full Text] [PDF]

				C. Fernandez-Tornero, R. M. Lozano, G. Rivas, M. A. Jimenez, L. Standker, D. Diaz-Gonzalez, W.-G. Forssmann, P. Cuevas, A. Romero, and G. Gimenez-Gallego Synthesis of the Blood Circulating C-terminal Fragment of Insulin-like Growth Factor (IGF)-binding Protein-4 in Its Native Conformation: CRYSTALLIZATION, HEPARIN AND IGF BINDING, AND OSTEOGENIC ACTIVITY J. Biol. Chem., May 13, 2005; 280(19): 18899 - 18907. [Abstract] [Full Text] [PDF]

				S. L. Krueckl, R. A. Sikes, N. M. Edlund, R. H. Bell, A. Hurtado-Coll, L. Fazli, M. E. Gleave, and M. E. Cox Increased Insulin-Like Growth Factor I Receptor Expression and Signaling Are Components of Androgen-Independent Progression in a Lineage-Derived Prostate Cancer Progression Model Cancer Res., December 1, 2004; 64(23): 8620 - 8629. [Abstract] [Full Text] [PDF]

				T. L. Wadsworth, J. M. Carroll, R. A. Mallinson, C. T. Roberts Jr., and C. E. Roselli Saw Palmetto Extract Suppresses Insulin-Like Growth Factor-I Signaling and Induces Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase Phosphorylation in Human Prostate Epithelial Cells Endocrinology, July 1, 2004; 145(7): 3205 - 3214. [Abstract] [Full Text] [PDF]

				C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				A. M. Mikheev, S. A. Mikheeva, B. Liu, P. Cohen, and H. Zarbl A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation Carcinogenesis, January 1, 2004; 25(1): 47 - 59. [Abstract] [Full Text] [PDF]

				E. A. Platz, M. F. Leitzmann, D. S. Michaud, W. C. Willett, and E. Giovannucci Interrelation of Energy Intake, Body Size, and Physical Activity with Prostate Cancer in a Large Prospective Cohort Study Cancer Res., December 1, 2003; 63(23): 8542 - 8548. [Abstract] [Full Text] [PDF]

				D. Spentzos, C. Mantzoros, M. M. Regan, M. E. Morrissey, S. Duggan, S. Flickner-Garvey, H. McCormick, W. DeWolf, S. Balk, and G. J. Bubley Minimal Effect of a Low-Fat/High Soy Diet for Asymptomatic, Hormonally Naive Prostate Cancer Patients Clin. Cancer Res., August 1, 2003; 9(9): 3282 - 3287. [Abstract] [Full Text] [PDF]

				K. Woodson, J. A. Tangrea, M. Pollak, T. D. Copeland, P. R. Taylor, J. Virtamo, and D. Albanes Serum Insulin-like Growth Factor I: Tumor Marker or Etiologic Factor? A Prospective Study of Prostate Cancer among Finnish Men Cancer Res., July 15, 2003; 63(14): 3991 - 3994. [Abstract] [Full Text] [PDF]

				S. Kiyama, K. Morrison, T. Zellweger, M. Akbari, M. Cox, D. Yu, H. Miyake, and M. E. Gleave Castration-Induced Increases in Insulin-Like Growth Factor-Binding Protein 2 Promotes Proliferation of Androgen-independent Human Prostate LNCaP Tumors Cancer Res., July 1, 2003; 63(13): 3575 - 3584. [Abstract] [Full Text] [PDF]

				T. Standal, M. Borset, S. Lenhoff, F. Wisloff, B. Stordal, A. Sundan, A. Waage, and C. Seidel Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor Blood, December 1, 2002; 100(12): 3925 - 3929. [Abstract] [Full Text] [PDF]

				O. Kucuk, F. H. Sarkar, Z. Djuric, W. Sakr, M. N. Pollak, F. Khachik, M. Banerjee, J. S. Bertram, and D. P. Wood Jr Effects of Lycopene Supplementation in Patients with Localized Prostate Cancer Experimental Biology and Medicine, November 1, 2002; 227(10): 881 - 885. [Abstract] [Full Text] [PDF]

				E. A. Platz Energy Imbalance and Prostate Cancer J. Nutr., November 1, 2002; 132(11): 3471S - 3481. [Abstract] [Full Text] [PDF]

				J. M. Chan, M. J. Stampfer, J. Ma, P. Gann, J. M. Gaziano, M. Pollak, and E. Giovannucci Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 as Predictors of Advanced-Stage Prostate Cancer J Natl Cancer Inst, July 17, 2002; 94(14): 1099 - 1106. [Abstract] [Full Text] [PDF]

				G. O. Hellawell, G. D. H. Turner, D. R. Davies, R. Poulsom, S. F. Brewster, and V. M. Macaulay Expression of the Type 1 Insulin-like Growth Factor Receptor Is Up-Regulated in Primary Prostate Cancer and Commonly Persists in Metastatic Disease Cancer Res., May 1, 2002; 62(10): 2942 - 2950. [Abstract] [Full Text] [PDF]

				R. D. Klein and S. M. Fischer Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells Carcinogenesis, January 1, 2002; 23(1): 217 - 221. [Abstract] [Full Text] [PDF]

				S.-F. Wu, H.-Z. Sun, X.-D. Qi, and Z.-H. Tu Effect of Epristeride on the Expression of IGF-1 and TGF-{beta} Receptors in Androgen-Induced Castrated Rat Prostate Experimental Biology and Medicine, November 1, 2001; 226(10): 954 - 960. [Abstract] [Full Text] [PDF]

				O. Kucuk, F. H. Sarkar, W. Sakr, Z. Djuric, M. N. Pollak, F. Khachik, Y.-W. Li, M. Banerjee, D. Grignon, J. S. Bertram, et al. Phase II Randomized Clinical Trial of Lycopene Supplementation before Radical Prostatectomy Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 861 - 868. [Abstract] [Full Text] [PDF]

				T. Nickerson, F. Chang, D. Lorimer, S. P. Smeekens, C. L. Sawyers, and M. Pollak In Vivo Progression of LAPC-9 and LNCaP Prostate Cancer Models to Androgen Independence Is Associated with Increased Expression of Insulin-like Growth Factor I (IGF-I) and IGF-I Receptor (IGF-IR) Cancer Res., August 1, 2001; 61(16): 6276 - 6280. [Abstract] [Full Text] [PDF]

				A. P. Chokkalingam, M. Pollak, C.-M. Fillmore, Y.-T. Gao, F. Z. Stanczyk, J. Deng, I. A. Sesterhenn, F. K. Mostofi, T. R. Fears, M. P. Madigan, et al. Insulin-like Growth Factors and Prostate Cancer: A Population-based Case-Control Study in China Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 421 - 427. [Abstract] [Full Text]

				R. H. Drivdahl, C. Sprenger, K. Trimm, and S. R. Plymate Inhibition of Growth and Increased Expression of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and -6 in Prostate Cancer Cells Stably Transfected with Antisense IGFBP-4 Complementary Deoxyribonucleic Acid Endocrinology, May 1, 2001; 142(5): 1990 - 1998. [Abstract] [Full Text]

				G. M. Yousef and E. P. Diamandis The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease Endocr. Rev., April 1, 2001; 22(2): 184 - 204. [Abstract] [Full Text]

				S. Monti, F. Di Silverio, R. Iraci, C. Martini, S. Lanzara, P. Falasca, M. Poggi, A. Stigliano, F. Sciarra, and V. Toscano Regional Variations of Insulin-Like Growth Factor I (IGF-I), IGF-II, and Receptor Type 1 in Benign Prostatic Hyperplasia Tissue and Their Correlation with Intraprostatic Androgens J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1700 - 1706. [Abstract] [Full Text]

				P. Stattin, A. Bylund, S. Rinaldi, C. Biessy, H. Dechaud, U.-H. Stenman, L. Egevad, E. Riboli, G. Hallmans, and R. Kaaks Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study J Natl Cancer Inst, December 6, 2000; 92(23): 1910 - 1917. [Abstract] [Full Text] [PDF]

				S. M. Harman, E. J. Metter, M. R. Blackman, P. K. Landis, and H. B. Carter Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4258 - 4265. [Abstract] [Full Text]

				N. Sueoka, H.-Y. Lee, G. L. Walsh, B. Fang, L. Ji, J. A. Roth, R. LaPushin, W. K. Hong, P. Cohen, and J. M. Kurie Insulin-Like Growth Factor Binding Protein-6 Inhibits the Growth of Human Bronchial Epithelial Cells and Increases in Abundance with All-trans-Retinoic Acid Treatment Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 297 - 303. [Abstract] [Full Text]

				E. P. Diamandis Prostate-specific Antigen: A Cancer Fighter and a Valuable Messenger? Clin. Chem., July 1, 2000; 46(7): 896 - 900. [Abstract] [Full Text] [PDF]

				H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text]

				J. DiGiovanni, K. Kiguchi, A. Frijhoff, E. Wilker, D. K. Bol, L. Beltran, S. Moats, A. Ramirez, J. Jorcano, and C. Conti Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice PNAS, March 28, 2000; 97(7): 3455 - 3460. [Abstract] [Full Text] [PDF]

				T. Shaneyfelt, R. Husein, G. Bubley, and C. S. Mantzoros Hormonal Predictors of Prostate Cancer: A Meta-Analysis J. Clin. Oncol., February 14, 2000; 18(4): 847 - 847. [Abstract] [Full Text] [PDF]

				M. A. Sortino, F. Condorelli, C. Vancheri, A. Chiarenza, R. Bernardini, U. Consoli, and P. L. Canonico Mitogenic Effect of Nerve Growth Factor (NGF) in LNCaP Prostate Adenocarcinoma Cells: Role of the High- and Low-Affinity NGF Receptors Mol. Endocrinol., January 1, 2000; 14(1): 124 - 136. [Abstract] [Full Text]

				E. A. Platz, M. N. Pollak, E. B. Rimm, N. Majeed, Y. Tao, W. C. Willett, and E. Giovannucci Racial Variation in Insulin-Like Growth Factor-1 and Binding Protein-3 Concentrations in Middle-Aged Men Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1107 - 1110. [Abstract] [Full Text]

				L. B. Signorello, K. Brismar, R. Bergstrom, S.-O. Andersson, A. Wolk, D. Trichopoulos, and H.-O. Adami Insulin-Like Growth Factor-Binding Protein-1 and Prostate Cancer J Natl Cancer Inst, November 17, 1999; 91(22): 1965 - 1967. [Full Text] [PDF]

				L. Bubendorf, M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, H. Moch, N. Willi, et al. Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays J Natl Cancer Inst, October 20, 1999; 91(20): 1758 - 1764. [Abstract] [Full Text] [PDF]

				D. M. Sutkowski, R. L. Goode, J. Baniel, C. Teater, P. Cohen, A. M. McNulty, H. M. Hsiung, G. W. Becker, and B. L. Neubauer Growth Regulation of Prostatic Stromal Cells by Prostate-Specific Antigen J Natl Cancer Inst, October 6, 1999; 91(19): 1663 - 1669. [Abstract] [Full Text] [PDF]

				T. Nickerson, H. Miyake, M. E. Gleave, and M. Pollak Castration-induced Apoptosis of Androgen-dependent Shionogi Carcinoma Is Associated with Increased Expression of Genes Encoding Insulin-like Growth Factor-binding Proteins Cancer Res., July 1, 1999; 59(14): 3392 - 3395. [Abstract] [Full Text] [PDF]

				C. W. Gregory, D. Kim, P. Ye, A. J. D’Ercole, T. G. Pretlow, J. L. Mohler, and F. S. French Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft Endocrinology, May 1, 1999; 140(5): 2372 - 2381. [Abstract] [Full Text]

				P. Mukherjee, A. V. Sotnikov, H. J. Mangian, J.-R. Zhou, W. J. Visek, and S. K. Clinton Energy Intake and Prostate Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Expression J Natl Cancer Inst, March 17, 1999; 91(6): 512 - 523. [Abstract] [Full Text] [PDF]

				S. Manes, M. Llorente, R. A. Lacalle, C. Gomez-Mouton, L. Kremer, E. Mira, and C. Martinez-A The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells J. Biol. Chem., March 12, 1999; 274(11): 6935 - 6945. [Abstract] [Full Text] [PDF]

				R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208. [Abstract] [Full Text]

				V. Hwa, C. Tomasini-Sprenger, A. López Bermejo, R. G. Rosenfeld, and S. R. Plymate Characterization of Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Prostate Cells J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4355 - 4362. [Abstract] [Full Text]

				E. S. Grant, M. B. Ross, S. Ballard, A. Naylor, and F. K. Habib The Insulin-Like Growth Factor Type I Receptor Stimulates Growth and Suppresses Apoptosis in Prostatic Stromal Cells J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3252 - 3257. [Abstract] [Full Text]

				S. E. Damon, L. Maddison, J. L. Ware, and S. R. Plymate Overexpression of an Inhibitory Insulin-Like Growth Factor Binding Protein (IGFBP), IGFBP-4, Delays Onset of Prostate Tumor Formation Endocrinology, August 1, 1998; 139(8): 3456 - 3464. [Abstract] [Full Text] [PDF]

				N. Buchs, J.-P. Bonjour, and R. Rizzoli Renal Tubular Reabsorption of Phosphate Is Positively Related to the Extent of Bone Metastatic Load in Patients with Prostate Cancer J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1535 - 1541. [Abstract] [Full Text]

				P. J. Russell, S. Bennett, and P. Stricker Growth factor involvement in progression of prostate cancer Clin. Chem., April 1, 1998; 44(4): 705 - 723. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, C. H. Hennekens, and M. Pollak Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study Science, January 23, 1998; 279(5350): 563 - 566. [Abstract] [Full Text]

				Y. Yamanaka, E. M. Wilson, R. G. Rosenfeld, and Y. Oh Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins J. Biol. Chem., December 5, 1997; 272(49): 30729 - 30734. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				G. Dong, R. Rajah, T. Vu, A. R. Hoffman, R. G. Rosenfeld, C. T. Roberts Jr., D. M. Peehl, and P. Cohen Decreased Expression of Wilms' Tumor Gene WT-1 and Elevated Expression of Insulin Growth Factor-II (IGF-II) and Type 1 IGF Receptor Genes in Prostatic Stromal Cells from Patients with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2198 - 2203. [Abstract] [Full Text] [PDF]

				A. Flyvbjerg, O. Mogensen, B. Mogensen, and O. S. Nielsen Elevated Serum Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2) and Decreased IGFBP-3 in Epithelial Ovarian Cancer: Correlation with Cancer Antigen 125 and Tumor-Associated Trypsin Inhibitor J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2308 - 2313. [Abstract] [Full Text] [PDF]

				C. K. Ritchie, L. R. Andrews, K. G. Thomas, D. J. Tindall, and L. A. Fitzpatrick The Effects of Growth Factors Associated with Osteoblasts on Prostate Carcinoma Proliferation and Chemotaxis: Implications for the Development of Metastatic Disease Endocrinology, March 1, 1997; 138(3): 1145 - 1150. [Abstract] [Full Text] [PDF]

				Y. Oh, S. R. Nagalla, Y. Yamanaka, H.-S. Kim, E. Wilson, and R. G. Rosenfeld Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7. RECOMBINANT HUMAN mac25 PROTEIN SPECIFICALLY BINDS IGF-I AND -II J. Biol. Chem., November 29, 1996; 271(48): 30322 - 30325. [Abstract] [Full Text] [PDF]